Cancer Researcher Beatrice Mintz Dies at 100

Mintz’s experiments over her six-decade career were foundational to cancer and genetics research.

Written byNatalia Mesa, PhD
| 2 min read
Photo of older woman, dressed in blue, smiling and looking at the camera
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Beatrice Mintz, a pioneering cancer researcher and developmental biologist whose findings helped pave the way for less harmful chemotherapy and radiation treatments, died on January 3 in her home in Elkins Park, Pennsylvania. She was 100 years old.

The cause of her death was heart failure; Mintz also had dementia, Bob Spallone, her executor and former colleague at Fox Chase Cancer Center, tells The New York Times.

Mintz worked at Fox Chase for more than 60 years, making numerous contributions to cancer research. Perhaps the most notable was her demonstration that deadly cancer cells could be introduced into mouse embryos that would go on to develop into normal mice, which showed that cancer cells could be reined in by signals from surrounding tissue. Researchers have since built on this finding to develop cancer therapies that are less damaging to healthy tissue than chemotherapy and radiation.

Mintz was also an early ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies